SCHEMBL7261585

SCHEMBL7261585

COc1cc2c(NCc3cccnc3)nc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc2c(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.50
▸ CYP3A4 P08684 6/20 0.50
▸ CYP2D6 P10635 6/20 0.50
▸ CYP2C19 P33261 6/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ TSHR P16473 3/20 0.50
▸ USP2 O75604 3/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ ALOX15 P16050 2/20 0.50
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ LMNA P02545 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ CLK4 Q9HAZ1 2/20 0.48
▸ PDE5A O76074 5/20 0.48
▸ KDM4E B2RXH2 3/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ MAPT P10636 4/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7261557 0.85 PDE5A (0.55) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7266328 0.79 MEN1 (0.60) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7262666 0.75 PDE5A (0.38) ALDH1A1HSD17B10ALOX15PDE5AKDM4E
SCHEMBL5259886 0.73 HPGD (0.40) CYP1A2CYP3A4CYP2C19ALDH1A1HSD17B10
SCHEMBL5258158 0.72 GAA (0.40) CYP1A2CYP3A4CYP2C19ALDH1A1HSD17B10
SCHEMBL7268476 0.72 MEN1 (0.60) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7268684 0.71 MAPT (0.70) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL12998480 0.69 ULK1 (0.64) ALDH1A1KMT2APGK1GAA
SCHEMBL7286998 0.68 PDE5A (0.72) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7268690 0.68 PDE1B (0.57) CYP3A4ALDH1A1TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 — — US disclosed
Send feedback